Benzinga | Mar 25, 2021 04:08PM EDT

ADMA Biologics Says Revises Previous Guidance From Building 5-10 Plasma Collection Facilities By 2024 To Current Expectation Of Having 10 Or More Plasma Collection Facilities In Operation By 2024

Expanded Plasma Collection Center Network. With the approval of another plasma collection facility in early February, ADMA now has seven plasma collection facilities under its corporate umbrella at various stages of development and approval, including one facility pending Biologics License Application ("BLA") approval in the second half of this year, and two additional plasma collection centers which we intend to open and file BLAs during 2021. Accordingly, we have revised our previous guidance from building 5-10 plasma collection facilities by 2024 to our current expectation of having 10 or more plasma collection facilities in operation by 2024.